Intended for healthcare professionals


Hundreds of Chinese researchers are sanctioned after mass retraction

BMJ 2017; 358 doi: (Published 10 August 2017) Cite this as: BMJ 2017;358:j3838
  1. Owen Dyer
  1. Montreal

China’s regulatory authorities have taken disciplinary action against 486 researchers found to have committed misconduct in a peer review scandal that rocked Chinese science.

The publisher Springer Nature announced in April that one of its journals, Tumor Biology, was retracting 107 papers because of fake peer reviews.1 Springer’s investigation found that some authors, who were allowed to suggest potential reviewers and forward their email addresses, had provided addresses leading to companies that offered fake peer reviews.

China’s ministry of science and technology, alarmed that the incident had “seriously harmed the international reputation of our country’s scientific profession and the dignity of …

View Full Text

Log in

Log in through your institution


* For online subscription